18F-DCFPyL Uptake in an Incidentally Detected Follicular Lymphoma by PET/CT Performed for Biochemically Recurrent Prostate Cancer

Dennie Meijer, Maurits Wondergem, Remco J. J. Knol, Wouter A. M. Broos, Friso M. van der Zant

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

A 75-year-old man, treated with curative intent for histopathologically proven prostate cancer (initial prostate-specific antigen, 27 ng/mL; Gleason 4 + 5 = 9) through external beam radiation therapy in 2010 in combination with 3 years of androgen deprivation therapy (leuprorelin), underwent F-DCFPyL PET/CT for biochemical recurrence with a prostate-specific antigen of 4.1 ng/mL in February 2019. Multiple pelvic and some para-aortic lymph nodes showed highly increased F-DCFPyL uptake, suspicious for metastases. Incidentally, a solid mesenteric mass and mesenteric lymph nodes with moderately increased F-DCFPyL uptake were found. Upon histopathological evaluation, this proved to be a low-grade follicular lymphoma.
Original languageEnglish
Pages (from-to)e96-e97
JournalClinical Nuclear Medicine
Volume45
Issue number2
DOIs
Publication statusPublished - 2020

Cite this

Meijer, Dennie ; Wondergem, Maurits ; Knol, Remco J. J. ; Broos, Wouter A. M. ; van der Zant, Friso M. / 18F-DCFPyL Uptake in an Incidentally Detected Follicular Lymphoma by PET/CT Performed for Biochemically Recurrent Prostate Cancer. In: Clinical Nuclear Medicine. 2020 ; Vol. 45, No. 2. pp. e96-e97.
@article{601c40b6b505456897fcf4419e36a8e8,
title = "18F-DCFPyL Uptake in an Incidentally Detected Follicular Lymphoma by PET/CT Performed for Biochemically Recurrent Prostate Cancer",
abstract = "A 75-year-old man, treated with curative intent for histopathologically proven prostate cancer (initial prostate-specific antigen, 27 ng/mL; Gleason 4 + 5 = 9) through external beam radiation therapy in 2010 in combination with 3 years of androgen deprivation therapy (leuprorelin), underwent F-DCFPyL PET/CT for biochemical recurrence with a prostate-specific antigen of 4.1 ng/mL in February 2019. Multiple pelvic and some para-aortic lymph nodes showed highly increased F-DCFPyL uptake, suspicious for metastases. Incidentally, a solid mesenteric mass and mesenteric lymph nodes with moderately increased F-DCFPyL uptake were found. Upon histopathological evaluation, this proved to be a low-grade follicular lymphoma.",
author = "Dennie Meijer and Maurits Wondergem and Knol, {Remco J. J.} and Broos, {Wouter A. M.} and {van der Zant}, {Friso M.}",
year = "2020",
doi = "10.1097/RLU.0000000000002738",
language = "English",
volume = "45",
pages = "e96--e97",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

18F-DCFPyL Uptake in an Incidentally Detected Follicular Lymphoma by PET/CT Performed for Biochemically Recurrent Prostate Cancer. / Meijer, Dennie; Wondergem, Maurits; Knol, Remco J. J.; Broos, Wouter A. M.; van der Zant, Friso M.

In: Clinical Nuclear Medicine, Vol. 45, No. 2, 2020, p. e96-e97.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - 18F-DCFPyL Uptake in an Incidentally Detected Follicular Lymphoma by PET/CT Performed for Biochemically Recurrent Prostate Cancer

AU - Meijer, Dennie

AU - Wondergem, Maurits

AU - Knol, Remco J. J.

AU - Broos, Wouter A. M.

AU - van der Zant, Friso M.

PY - 2020

Y1 - 2020

N2 - A 75-year-old man, treated with curative intent for histopathologically proven prostate cancer (initial prostate-specific antigen, 27 ng/mL; Gleason 4 + 5 = 9) through external beam radiation therapy in 2010 in combination with 3 years of androgen deprivation therapy (leuprorelin), underwent F-DCFPyL PET/CT for biochemical recurrence with a prostate-specific antigen of 4.1 ng/mL in February 2019. Multiple pelvic and some para-aortic lymph nodes showed highly increased F-DCFPyL uptake, suspicious for metastases. Incidentally, a solid mesenteric mass and mesenteric lymph nodes with moderately increased F-DCFPyL uptake were found. Upon histopathological evaluation, this proved to be a low-grade follicular lymphoma.

AB - A 75-year-old man, treated with curative intent for histopathologically proven prostate cancer (initial prostate-specific antigen, 27 ng/mL; Gleason 4 + 5 = 9) through external beam radiation therapy in 2010 in combination with 3 years of androgen deprivation therapy (leuprorelin), underwent F-DCFPyL PET/CT for biochemical recurrence with a prostate-specific antigen of 4.1 ng/mL in February 2019. Multiple pelvic and some para-aortic lymph nodes showed highly increased F-DCFPyL uptake, suspicious for metastases. Incidentally, a solid mesenteric mass and mesenteric lymph nodes with moderately increased F-DCFPyL uptake were found. Upon histopathological evaluation, this proved to be a low-grade follicular lymphoma.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85077401631&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/31361646

U2 - 10.1097/RLU.0000000000002738

DO - 10.1097/RLU.0000000000002738

M3 - Article

VL - 45

SP - e96-e97

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 2

ER -